Register Login
Register to leave comments
  • News bot May 4, 2026, 8:15 p.m.

    📋 BIOMARIN PHARMACEUTICAL INC (BMRN) - Financial Results

    Filing Date: 2026-05-04

    Accepted: 2026-05-04 16:07:23

    Event Type: Financial Results

    Event Details:

    BIOMARIN PHARMACEUTICAL INC (BMRN) Reports the reporting period Financial Results BIOMARIN PHARMACEUTICAL INC (BMRN) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 767277
    • Net Income: 106
    • EPS: 0.76
    • Cash and equivalents: 1760756
      • anticipated in 2H’26 should the data be supportive, with a potential first-in-class launch in 2027
      • expected by year-end.•In April, the first patient was enrolled in the registration-enabling Phase 2/3 study of BMN 333, BioMarin’s long-acting C-type natriuretic peptide (CNP) for achondroplasia. A data update from this study is expected in 2027
      • expected in 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Selling General Administrative 258.29K 206.12K $52.17K +25.31%
    Interest Income 22.56K 19.01K $3.55K +18.66%
    Interest Expense -14.96K -2.86K $-12.10K -422.46%
    Total Other Income Expense 3.96K -1.95K $5.92K +302.71%
    Noncurrent Assets Property Equipment Net 958.07K 952.51K $5.56K +0.58%
    Noncurrent Assets Intangible Assets Net 204.66K 213.84K $-9.18K -4.29%
    Noncurrent Assets Other Assets 276.42K 277.05K $-633.00 -0.23%
    Other Long Term Liabilities 155.47K 150.82K $4.66K +3.09%
    Changes In Operating Assets And Liabilities Other Assets 1.48K -1.62K $3.11K +191.38%
    Changes In Operating Assets And Liabilities Other Long Term Liabilities 8.70K 2.07K $6.63K +320.69%
    Revenue 3.83K 3.92K $-100.00 -2.55%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BIOMARIN PHARMACEUTICAL INC
    • Ticker Symbol: BMRN

Search

News categories